Ionis Pharmaceuticals Inc (IONS)
35.64
+0.05
(+0.14%)
USD |
NASDAQ |
Dec 20, 16:00
35.50
-0.14
(-0.39%)
After-Hours: 20:00
Ionis Pharmaceuticals Profit Margin (Quarterly): -105.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 15.76% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Apellis Pharmaceuticals Inc | -29.19% |
| Moderna Inc | 0.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.21% |
| Return on Assets | -12.41% |
| Return on Invested Capital | -21.57% |
| Gross Profit Margin (Quarterly) | 99.20% |
| Operating Margin (Quarterly) | -111.1% |
| Return on Net Operating Assets | -108.6% |